article Open Access
Clinical and economic benefits of human skin allografts in severe burn management: A systematic umbrella review
International Journal of Applied Research · 2025 · Vol. 11(5) · pp. 94–99
Sarita Yadav✉(Nepal Medical College Teaching Hospital)Kiran Nakarmi(Patan Hospital)Bishal Karki(Nepal Medical College Teaching Hospital)Sushant Rai(Patan Hospital)Mythri ShankarKamal PathakXu Yong QingBabita Yada
Abstract
Human skin allografts (HSAs) have emerged as a promising treatment for severe burns, yet their clinical and economic benefits compared to standard therapies remain incompletely characterized. This systematic review analysed 30 studies (2010-2023) from PubMed/Web of Science, including randomized trials, meta-analyses and observational studies. We evaluated clinical outcomes (healing time, infection rates, mortality) and economic impacts (cost savings, resource utilization) using AMSTAR 2 for quality assessment. HSAs demonstrated superior outcomes versus alternatives: 32-45% lower infection rates (OR 0.62, p
Citations
0
FWCI
0.00
field-weighted impact
References
6
Percentile
14%
vs. same field & year
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.